Integrated Quantitative Investments LLC purchased a new position in Plexus Corp. (NASDAQ:PLXS - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 7,500 shares of the technology company's stock, valued at approximately $1,174,000.
A number of other large investors have also made changes to their positions in the business. TD Private Client Wealth LLC acquired a new position in Plexus during the 4th quarter valued at about $28,000. Quarry LP increased its holdings in shares of Plexus by 573.5% during the third quarter. Quarry LP now owns 229 shares of the technology company's stock valued at $31,000 after acquiring an additional 195 shares in the last quarter. R Squared Ltd acquired a new position in shares of Plexus during the fourth quarter valued at about $45,000. Nomura Asset Management Co. Ltd. raised its position in shares of Plexus by 45.5% in the 4th quarter. Nomura Asset Management Co. Ltd. now owns 320 shares of the technology company's stock valued at $50,000 after purchasing an additional 100 shares during the last quarter. Finally, USA Financial Formulas acquired a new stake in Plexus in the 4th quarter worth approximately $56,000. 94.45% of the stock is owned by institutional investors and hedge funds.
Insider Buying and Selling at Plexus
In other Plexus news, CEO Todd P. Kelsey sold 1,500 shares of the firm's stock in a transaction on Monday, February 3rd. The stock was sold at an average price of $136.96, for a total value of $205,440.00. Following the transaction, the chief executive officer now owns 86,932 shares in the company, valued at approximately $11,906,206.72. This trade represents a 1.70 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Michael J. Running sold 1,250 shares of the company's stock in a transaction on Friday, February 21st. The stock was sold at an average price of $138.62, for a total transaction of $173,275.00. Following the sale, the insider now directly owns 1,276 shares of the company's stock, valued at $176,879.12. The trade was a 49.49 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 17,958 shares of company stock valued at $2,551,930 over the last quarter. 1.76% of the stock is currently owned by insiders.
Analyst Ratings Changes
A number of research firms have issued reports on PLXS. Benchmark reaffirmed a "buy" rating and issued a $165.00 price target on shares of Plexus in a report on Wednesday, January 22nd. Stifel Nicolaus assumed coverage on Plexus in a research note on Tuesday, February 4th. They issued a "hold" rating and a $152.00 target price for the company. Finally, Needham & Company LLC boosted their price target on Plexus from $162.00 to $172.00 and gave the company a "buy" rating in a research note on Friday, January 24th. Two investment analysts have rated the stock with a hold rating and three have given a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $163.00.
Get Our Latest Stock Report on PLXS
Plexus Stock Performance
Shares of Plexus stock traded up $3.82 during trading on Wednesday, hitting $114.77. 91,047 shares of the company's stock were exchanged, compared to its average volume of 161,579. Plexus Corp. has a 52-week low of $92.72 and a 52-week high of $172.89. The company has a debt-to-equity ratio of 0.07, a quick ratio of 0.70 and a current ratio of 1.53. The stock has a market capitalization of $3.10 billion, a price-to-earnings ratio of 26.75 and a beta of 0.83. The business has a 50-day simple moving average of $130.66 and a 200-day simple moving average of $145.39.
Plexus (NASDAQ:PLXS - Get Free Report) last announced its earnings results on Wednesday, January 22nd. The technology company reported $1.49 earnings per share for the quarter, missing the consensus estimate of $1.59 by ($0.10). Plexus had a return on equity of 10.36% and a net margin of 3.03%. On average, research analysts forecast that Plexus Corp. will post 5.9 EPS for the current year.
About Plexus
(
Free Report)
Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.
Featured Stories

Before you consider Plexus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Plexus wasn't on the list.
While Plexus currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.